These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16915750)

  • 1. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
    Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
    Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group.
    Zanchetti A; Crepaldi G; Bond MG; Gallus GV; Veglia F; Ventura A; Mancia G; Baggio G; Sampieri L; Rubba P; Collatina S; Serrotti E
    J Hypertens; 2001 Jan; 19(1):79-88. PubMed ID: 11204308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
    Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A;
    Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study.
    Hoffmann U; Globits S; Stefenelli T; Loewe C; Kostner K; Frank H
    J Magn Reson Imaging; 2001 Jul; 14(1):16-22. PubMed ID: 11436209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fosinopril sodium on early carotid atherosclerosis in diabetic patients with hypertension.
    Migdalis IN; Gerolimou B; Kozanidou G; Hatzigakis SM; Karmaniolas KD
    J Med; 1997; 28(5-6):371-80. PubMed ID: 9604795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
    Cheung BM; Lau CP
    Br J Clin Pharmacol; 1999 Feb; 47(2):179-87. PubMed ID: 10190653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow.
    Andersson PE; Lind L; Andrén B; Hänni A; Reneland R; Berne C; Lithell H
    Blood Press; 1998 May; 7(2):118-26. PubMed ID: 9657539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid intima media thickness, left ventricular hypertrophy and weekly averaged blood pressure in hemodialysis patients.
    Abdallah E; Waked E; Nabil M; Abdel-Khalek A; Metwally A
    J Egypt Soc Parasitol; 2011 Apr; 41(1):141-54. PubMed ID: 21634250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
    J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
    Mörtsell D; Malmqvist K; Held C; Kahan T
    J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
    Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
    Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats.
    Yu G; Liang X; Xie X; Su M; Zhao S
    Int J Cardiol; 2001 Dec; 81(2-3):123-9; discussion 129-30. PubMed ID: 11744126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
    Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
    Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
    Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
    Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
    Laufer E; Reid C; Qi XL; Jennings GL
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.